Integra LifeSciences IART Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's operating lease liabilities (current)?
- Integra LifeSciences (IART) reported operating lease liabilities (current) of $13.93M in Q1 2026.
- How has Integra LifeSciences's operating lease liabilities (current) changed year-over-year?
- Integra LifeSciences's operating lease liabilities (current) decreased by 1.7% year-over-year, from $14.17M to $13.93M.
- What is the long-term trend for Integra LifeSciences's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Integra LifeSciences's operating lease liabilities (current) has grown at a 1.8% compound annual growth rate (CAGR), from $12.82M to $14.02M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.